跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
JERAYGO - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
JERAYGO
Authorized
STANDARD
JERAYGO
Idorsia Pharmaceuticals Ltd
🇨🇦 Health Canada
Approval Date
Feb 5, 2026
Approval ID
f0a9fbe3e33f0d01
Company
Idorsia Pharmaceuticals Ltd
Type
Standard
Approval Details
Approval Id
f0a9fbe3e33f0d01
Drug Approval Canada Name
JERAYGO
Product Name
JERAYGO
Status
Approved
Status Date
2025-12-23
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription Recommended
Ahfs
24:52
Atc Original
C02KN01 APROCITENTAN
Aig Number
0167974001
Company Name
Idorsia Pharmaceuticals Ltd
Company Address
Hegenheimermattweg 91 Allschwil Basel-Landschaft Switzerland 4123
Company Detail Path
/organization/idorsia-pharmaceuticals-ltd
Company Information
Pharmaceutical Company Name
Idorsia Pharmaceuticals Ltd
Country Name
Switzerland
Province Name
Basel-Land
City Name
allschwil,basel-land,country_ch
Address
Hegenheimermattweg 91
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 5, 2026
Approval ID
f0a9fbe3e33f0d01
Type
Standard
Back to Health Canada Approvals